Detalhe da pesquisa
1.
Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy.
Cancers (Basel)
; 16(11)2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38893255
2.
Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT).
Clin Lung Cancer
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38705835
3.
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study.
Front Oncol
; 14: 1305720, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406805
4.
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma.
Eur J Cancer
; 196: 113441, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988842
5.
Epigenetic Therapies and Biomarkers in Breast Cancer.
Cancers (Basel)
; 14(3)2022 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158742